GSK to cut 1,000 R&D jobs
GlaxoSmithKline, Britian's largest pharmaceuticals firm, plans to axe almost 1,000 people at its American and British R&D units. The cuts are likely to improve productivity and save costs.
Image: The GlaxoSmithKline headquarters in west London. | Photograph: Odd Andersen/AFP/Getty Images
Also read: An Indian may bag the Economics Nobel this time